GoAI
Get started
Morishita Jintan Co., Ltd. logo

Morishita Jintan Co., Ltd.

4524.T

JPXHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Latest quote

¥2,247

+¥9.00 · +0.40%

Aug 24, 9:15 AM JST

4524.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Morishita Jintan Co., Ltd. is a Japanese enterprise that manufactures and distributes a diverse array of products, encompassing pharmaceuticals, quasi-pharmaceuticals, medical devices, and food items. The company's operations are divided into two main segments: Healthcare Business and Capsule Business. The Healthcare Business division is responsible for the production and sale of its proprietary Jintan branded goods, and also provides original equipment manufacturing (OEM) services for dietary supplements, cosmetic products, and various food items. Concurrently, the Capsule Business division handles both original equipment and design manufacturing (OEM/ODM) for pharmaceutical and food sectors, in addition to innovating and developing capsules for industrial applications. Established in 1893, the company's headquarters are located in Osaka, Japan.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
JP
CEO
Yuji Morishita
Listed since
Jan 4, 2001
Employees
359

Market position

Day range

Current ¥2,247

52-week range

Current ¥2,247

Open
¥2,246
Previous close
¥2,238
Volume
1.1K
0.88× average
Average volume
1.25K
Average daily volume
Market cap
9.21B JPY
Beta
0.01
Market reference 1
50-day average
¥2,187.14
+2.74% above average
200-day average
¥2,209.74
+1.69% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
9.05B JPY
P/E (TTM)
11.67×
P/B (TTM)
0.71×
P/S (TTM)
0.72×
EV / EBITDA
7.02×
Earnings yield
6.89%
Free cash flow yield
0.20%
Dividend yield
2.89%

Profitability & efficiency

Gross margin
48.58%
Operating margin
7.14%
Net margin
6.15%
Return on equity
4.84%
Return on assets
3.37%
Return on invested capital
3.43%

Financial health

Debt / equity
0.13×
Current ratio
3.02×
Altman Z-score
2.66
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends56%37%17%-2%Gross margin, FY2021: 51.00%Gross margin, FY2022: 46.76%Gross margin, FY2023: 48.35%Gross margin, FY2024: 45.39%Gross margin, FY2025: 46.75%Operating margin, FY2021: 3.13%Operating margin, FY2022: 5.01%Operating margin, FY2023: 5.77%Operating margin, FY2024: 6.30%Operating margin, FY2025: 5.45%Net margin, FY2021: 2.96%Net margin, FY2022: 4.32%Net margin, FY2023: 5.62%Net margin, FY2024: 4.28%Net margin, FY2025: 4.95%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 51.00%. Gross margin FY2022 46.76%. Gross margin FY2023 48.35%. Gross margin FY2024 45.39%. Gross margin FY2025 46.75%. Operating margin FY2021 3.13%. Operating margin FY2022 5.01%. Operating margin FY2023 5.77%. Operating margin FY2024 6.30%. Operating margin FY2025 5.45%. Net margin FY2021 2.96%. Net margin FY2022 4.32%. Net margin FY2023 5.62%. Net margin FY2024 4.28%. Net margin FY2025 4.95%.

Income trends

Revenue

12.69B JPY-0.61%

Operating income

692M JPY-13.93%

Net income

628M JPY+14.81%
Income trends across reported periods14.01B JPY9.02B JPY4.03B JPY−965.3M JPYRevenue, FY2021: 9.56B JPYRevenue, FY2022: 11.36B JPYRevenue, FY2023: 12.41B JPYRevenue, FY2024: 12.77B JPYRevenue, FY2025: 12.69B JPYOperating income, FY2021: 299M JPYOperating income, FY2022: 569M JPYOperating income, FY2023: 716M JPYOperating income, FY2024: 804M JPYOperating income, FY2025: 692M JPYNet income, FY2021: 283M JPYNet income, FY2022: 491M JPYNet income, FY2023: 697M JPYNet income, FY2024: 547M JPYNet income, FY2025: 628M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 9.56B JPY. Revenue FY2022 11.36B JPY. Revenue FY2023 12.41B JPY. Revenue FY2024 12.77B JPY. Revenue FY2025 12.69B JPY. Operating income FY2021 299M JPY. Operating income FY2022 569M JPY. Operating income FY2023 716M JPY. Operating income FY2024 804M JPY. Operating income FY2025 692M JPY. Net income FY2021 283M JPY. Net income FY2022 491M JPY. Net income FY2023 697M JPY. Net income FY2024 547M JPY. Net income FY2025 628M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue12.69B JPY12.77B JPY12.41B JPY11.36B JPY9.56B JPY
Cost of goods sold6.76B JPY6.97B JPY6.41B JPY6.05B JPY4.69B JPY
Gross profit5.93B JPY5.79B JPY6B JPY5.31B JPY4.88B JPY
Research and development1.12B JPY1.11B JPY957M JPY849M JPY850M JPY
Selling, general, and administrative4.13B JPY3.88B JPY4.13B JPY3.7B JPY3.57B JPY
Operating expenses5.24B JPY4.99B JPY5.28B JPY4.74B JPY4.57B JPY
Interest income1M JPY———1M JPY
Interest expense22M JPY8M JPY2M JPY2M JPY7M JPY
Depreciation and amortization596M JPY578M JPY576M JPY627M JPY585M JPY
Operating income692M JPY804M JPY716M JPY569M JPY299M JPY
Net income628M JPY547M JPY697M JPY491M JPY283M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
79.24

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates86.8150.2213.62-22.97Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 12, 2024: actual -15.4, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 40.98, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 13, 2025: actual 48.07, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 7, 2025: actual 39.87, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 12, 2025: actual 13.1, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 12, 2026: actual 35.67, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 13, 2026: actual 64.89, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 6, 2026: actual 79.24, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates3.62B3.35B3.09B2.83BQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 12, 2024: actual 2.97B JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 3.21B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 13, 2025: actual 3.17B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 7, 2025: actual 3.34B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 12, 2025: actual 3.17B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 12, 2026: actual 3.19B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 13, 2026: actual 2.98B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 6, 2026: actual 3.48B JPY, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥55.00

2025 complete year+46.7% since 2021

2026 partial: ¥65.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Mar 30, 2027

¥65.00

Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥65.00

Annual

Record Mar 31, 2026 · Payment Jun 26, 2026

Dividend

Ex-dividend Mar 28, 2025

¥55.00

Annual

Record Mar 31, 2025 · Payment Jun 26, 2025

Dividend

Ex-dividend Mar 28, 2024

¥50.00

Annual

Record Mar 31, 2024 · Payment Jun 27, 2024

Dividend

Ex-dividend Mar 30, 2023

¥40.00

Annual

Record Mar 31, 2023 · Payment Jun 30, 2023

Dividend

Ex-dividend Mar 30, 2022

¥37.50

Annual

Record Mar 31, 2022 · Payment Jun 30, 2022

4524.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,008

-0.04%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,799

+0.61%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,990

+0.38%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,392.5

+0.23%

Continue in GoAI

Research 4524.T

research.disclaimer